BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

574 related articles for article (PubMed ID: 19840798)

  • 1. Cost-effectiveness of endoscopic screening followed by surveillance for Barrett's esophagus: a review.
    Barbiere JM; Lyratzopoulos G
    Gastroenterology; 2009 Dec; 137(6):1869-76. PubMed ID: 19840798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An economic analysis of endoscopic ablative therapy for management of nondysplastic Barrett's esophagus.
    Das A; Wells C; Kim HJ; Fleischer DE; Crowell MD; Sharma VK
    Endoscopy; 2009 May; 41(5):400-8. PubMed ID: 19418393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost utility of screening for Barrett's esophagus with esophageal capsule endoscopy versus conventional upper endoscopy.
    Rubenstein JH; Inadomi JM; Brill JV; Eisen GM
    Clin Gastroenterol Hepatol; 2007 Mar; 5(3):312-8. PubMed ID: 17368230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are screening and surveillance for Barrett's oesophagus really worthwhile?
    Sharma P; Sidorenko EI
    Gut; 2005 Mar; 54 Suppl 1(Suppl 1):i27-32. PubMed ID: 15711005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for Barrett's esophagus.
    Spechler SJ
    Rev Gastroenterol Disord; 2002; 2 Suppl 2():S25-9. PubMed ID: 12478241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving screening practices for Barrett's esophagus.
    Shaheen NJ; Palmer LB
    Surg Oncol Clin N Am; 2009 Jul; 18(3):423-37. PubMed ID: 19500734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-benefit analysis of capsule endoscopy compared with standard upper endoscopy for the detection of Barrett's esophagus.
    Gerson L; Lin OS
    Clin Gastroenterol Hepatol; 2007 Mar; 5(3):319-25. PubMed ID: 17368231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incongruence between histologic and endoscopic diagnoses of Barrett's esophagus using transnasal esophagoscopy.
    Halum SL; Postma GN; Bates DD; Koufman JA
    Laryngoscope; 2006 Feb; 116(2):303-6. PubMed ID: 16467724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening and surveillance of Barrett's esophagus.
    Regula J
    Dig Dis; 2009; 27(1):54-7. PubMed ID: 19439961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The rationale for screening and surveillance of Barrett's metaplasia.
    Wani S; Sharma P
    Best Pract Res Clin Gastroenterol; 2006; 20(5):829-42. PubMed ID: 16997164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-Analyses Studies in Barrett's Esophagus: What Is Their Utility?
    Gerson LB
    Gastroenterol Clin North Am; 2015 Jun; 44(2):425-38. PubMed ID: 26021203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GERD and Barrett's esophagus: diagnostic and management strategies in the geriatric population.
    Morganstern B; Anandasabapathy S
    Geriatrics; 2009 Jul; 64(7):9-12. PubMed ID: 19586085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Barrett's esophagus: diagnostic approaches and surveillance.
    Schuchert MJ; McGrath K; Buenaventura PO
    Semin Thorac Cardiovasc Surg; 2005; 17(4):301-12. PubMed ID: 16428036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for and surveillance of Barrett's esophagus is clinically indicated.
    Cengia G; Missale G; Minelli L; Villanacci V; Rossi E; Cestari R
    Dig Dis; 2007; 25(3):197-202. PubMed ID: 17827939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How far to go? Screening and surveillance in Barrett's esophagus.
    Lieberman DA; Sampliner RE
    Am J Manag Care; 2001 Feb; 7(1 Suppl):S19-26. PubMed ID: 11225349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blinded comparison of esophageal capsule endoscopy versus conventional endoscopy for a diagnosis of Barrett's esophagus in patients with chronic gastroesophageal reflux.
    Lin OS; Schembre DB; Mergener K; Spaulding W; Lomah N; Ayub K; Brandabur JJ; Bredfeldt J; Drennan F; Gluck M; Jiranek GC; McCormick SE; Patterson D; Kozarek RA
    Gastrointest Endosc; 2007 Apr; 65(4):577-83. PubMed ID: 17324414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is endoscopic surveillance for non-dysplastic Barrett's esophagus cost-effective? Review of economic evaluations.
    Hirst NG; Gordon LG; Whiteman DC; Watson DI; Barendregt JJ
    J Gastroenterol Hepatol; 2011 Feb; 26(2):247-54. PubMed ID: 21261712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pretreatment endoscopy--pro & contra: endoscopy is needed before treatment in all patients with gastroesophageal reflux disease.
    Pace F; Manes G; Conio M; Bianchi Porro G
    Endoscopy; 2006 Mar; 38(3):271-5. PubMed ID: 16528655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Recommended endoscopic surveillance of patients with Barrett's esophagus (BE) is a cost-effective strategy?].
    Remes-Troche JM; Ramírez-Arias JF; Gómez-Escudero O; Valdovinos-Andraca F; Vargas-Vorácková F
    Rev Gastroenterol Mex; 2006; 71(1):46-54. PubMed ID: 17061478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of endoscopic surveillance of non-dysplastic Barrett's esophagus.
    Gordon LG; Mayne GC; Hirst NG; Bright T; Whiteman DC; ; Watson DI
    Gastrointest Endosc; 2014 Feb; 79(2):242-56.e6. PubMed ID: 24079411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.